Liste des affiches

Un aperçu du programme de tous les événements se trouve dans l’agenda

Filtre
Code
Titre
P01
P01: Serum S-100B Adds Incremental Value for the Prediction of Symptomatic Intracranial Hemorrhage and Symptomatic Brain Edema After Acute Ischemic Stroke: Data from the Multicentre BIOSIGNAL-Cohort Study
Poster 1. Neurovascular disorders
T. Honegger Conférencier UniversitätsSpital & Universität ZürichJ. Schweizer UniversitätsSpital & Universität ZürichA. Bicvic UniversitätsSpital & Universität ZürichL. Westphal UniversitätsSpital & Universität ZürichV. Schütz UniversitätsSpital & Universität ZürichC. Inauen UniversitätsSpital & Universität ZürichT. Pokorny UniversitätsSpital & Universität ZürichK. Bracher UniversitätsSpital & Universität ZürichM. Arnold Inselspital - Universitätsspital BernU. Fischer Inselspital - Universitätsspital BernL. Bonati Universitätsspital BaselG. De Marchis Universitätsspital BaselK. Nedeltchev Kantonsspital AarauT. Kahles Kantonsspital AarauC. Cereda Ente Ospedaliero Cantonale, Ospedale Regionale di LuganoG. Kägi Kantonsspital St. GallenJ. Montaner Hospital Universitari Vall d’HebronA. Bustamante Hospital Universitari Germans Trias i PujolE. Palà Vall d’Hebron Institute of Research, Universitat Autònoma de BarcelonaG. Ntaios University of Thessaly LarissaC. Foerch University Hospital Frankfurt am MainA. Luft UniversitätsSpital & Universität ZürichK. Spanaus UniversitätsSpital & Universität ZürichA. von Eckardstein UniversitätsSpital & Universität ZürichM. Arnold UniversitätsSpital & Universität ZürichM. Katan Kahles UniversitätsSpital & Universität Zürich
P02
P02: GENETIC PROXIES FOR PCSK9 INHIBITION ASSOCIATED WITH LOWER LIPOPROTEIN(A): EFFECTS ON CORONARY ARTERY DISEASE AND ISCHEMIC STROKE
Poster 1. Neurovascular disorders
G. De Marchis Unispital BaselT. Dittrich Conférencier Unispital BaselR. Malik Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-Universität LMU, MunichA. Zietz Unispital BaselL. Kriemler Unispital BaselB. Ference Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, United KingdomM. Dichgans Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-Universität LMU, Munich, GermanyM. Georgakis Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-Universität LMU, Munich, Germany
P03
P03: REPERFUSION THERAPIES OF ISOLATED POSTERIOR CEREBRAL ARTERY OCCLUSION: AN ANALYSIS OF THE SWISS STROKE REGISTRY (SSR)
Poster 1. Neurovascular disorders
F. Maulucci Stroke Center, Neurology, Neurocenter of Southern SwitzerlandG. Disanto Stroke Center, Neurology, Neurocenter of Southern SwitzerlandG. Bianco Stroke Center, Neurology, Neurocenter of Southern SwitzerlandM. Pileggi Stroke Center, Interventional and Diagnostic Neuroradiology, Neurocenter of Southern SwitzerlandG. Padlina University Hospital Bern, Department of NeurologyU. Fischer University Hospital Bern, Department of NeurologyD. Strambo Lausanne University Hospital, Stroke Center, Neurology ServiceP. Michel Lausanne University Hospital, Stroke Center, Neurology ServiceT. Kahles Kantonsspital Aarau, Department of NeurologyK. Nedeltchev Kantonsspital Aarau, Department of NeurologyU. Fischer University Hospital Basel and University of Basel, Department of Neurology and Stroke CenterL. Bonati University Hospital Basel and University of Basel, Department of Neurology and Stroke CenterG. Kägi Kantonsspital St. Gallen, Department of NeurologyA. Müller Kantonsspital St. Gallen, Department of NeurologyJ. Escribano Paredes Hôpitaux Universitaires de Genève, Department of NeurologyE. Carrera Hôpitaux Universitaires de Genève, Department of NeurologyT. Nyffeler Luzerner Kantonsspital, Center of Neurology and NeurorehabilitationM. Bolognese Luzerner Kantonsspital, Center of Neurology and NeurorehabilitationS. Wegener Universitätsspital Zürich, NeurologyA. Luft Universitätsspital Zürich, NeurologyL. Schelosky Kantonsspital Münsterlingen, Division of NeurologyF. Medlin HFR Fribourg, Stroke Unit, Division of NeurologyB. Rodic Kantonsspital Winterthur, NeurologyA. von Reding Kantonsspital Winterthur, NeurologyN. Peters Hirslanden Hospital, Department of Neurology and Stroke CenterR. Backhaus Hirslanden Hospital, Department of Neurology and Stroke CenterS. Renaud Pourtalès Hospital, Division of NeurologyM. Mono Stadtspital Waid und Triemli, Stroke UnitM. Psychogios University Hospital Basel, Department of NeuroradiologyJ. Kaesmacher University Hospital Bern, Inselspital, NeuroradiologyP. Mordasini University Hospital Bern, Inselspital, NeuroradiologyC. Cereda Conférencier Stroke Center, Neurology, Neurocenter of Southern Switzerland
P04
P04: A case report on Reversible Cerebral Vasoconstriction Syndrome and Transient Global Amnesia
Poster 1. Neurovascular disorders
F. Maibach Conférencier Hirslanden Zürich A. Czaplinski Hirslanden ZürichN. Peters Hirslanden Zürich/ Universität BaselA. Paliantonis Hirslanden Zürich
P05
P05: COVID-19 associated stroke and cerebral endotheliitis, a case report.
Poster 1. Neurovascular disorders
P. Stancu Conférencier Hôpitaux Universitaire de Genève HUG
P06
P06: Recurrent stroke in patients with atrial fibrillation – a possible underestimation of stroke etiologies other than cardioembolism?
Poster 1. Neurovascular disorders
A. Zietz Conférencier Department of Neurology and Stroke Center, University Hospital and University of BaselA. Polymeris Department of Neurology and Stroke Center, University Hospital and University of BaselF. Helfenstein Clinical Trial Unit, Department of Clinical Research, University Hospital BaselL. Hert University and University Hospital of BaselB. Wagner Department of Neurology and Stroke Center, University Hospital and University of BaselG. De Marchis Department of Neurology and Stroke Center, University Hospital and University of BaselH. Gensicke Department of Neurology and Stroke Center, University Hospital and University of BaselL. Bonati Department of Neurology and Stroke Center, University Hospital and University of BaselP. Lyrer Department of Neurology and Stroke Center, University Hospital and University of BaselS. Engelter Department of Neurology and Stroke Center, University Hospital and University of BaselN. Peters Stroke Center Hirslanden, Klinik Hirslanden Zurich and University Hospital of Basel
P07
P07: The role of electrocardiographic markers for prediction of atrial fibrillation in patients with acute ischemic stroke: data from the BIOSIGNAL cohort study
Poster 1. Neurovascular disorders
V. Schütz Conférencier K. Bracher UniversitätsSpital & Universität ZürichM. Arnold Univeristätsspital ZürichJ. Schweizer Univeristätsspital ZürichC. Nakas Inselspital - Universitätsspital BernL. Westphal UniversitätsSpital Zürich (USZ)C. Inauen Univeristätsspital ZürichT. Pokorny Univeristätsspital ZürichA. Luft Univeristätsspital ZürichK. Spanaus Univeristätsspital ZürichS. DougoudF. DuruA. SagunerM. Katan Kahles UniversitätsSpital Zürich (USZ)
P08
P08: The “Index Vein” is a highly specific sign for migraine aura in the emergency setting
Poster 1. Neurovascular disorders
A. Scutelnic Conférencier Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieV. Petroulia Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieL. Schraml Inselspital, Bern University Hospital and University of BernS. Jung Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieM. Branca CTU Bern, Institute of Social and Preventive Medicine, University of Bern, Bern, SwitzerlandM. Beyeler Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieU. Fischer Department of Neurology and Stroke Center, University Hospital and University of BaselR. Wiest Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieN. Slavova Universitäts-Kinderspital beider Basel (UKBB)C. Schankin Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
P09
P09: NEDA-3 status and MAGNIMS score in the first two years predict long-term disability: A single-centre cohort study
Poster 2. Neuroinflammation / Neuroinfection
M. Pistor Conférencier Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieL. Diem Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieH. Hammer Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieC. Friedli Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieN. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieF. Wagner Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieR. Wiest Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
P10
P10: Leptomeningeal enhancement under different immunotherapies – a monocentric retrospective cohort study of 215 patients
Poster 2. Neuroinflammation / Neuroinfection
C. Friedli Conférencier Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieF. Wagner Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieH. Hammer Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieN. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Wiest Inselspital - Universitätsspital Bern - Universitätsinstitut für Diagnostische und Interventionelle NeuroradiologieL. Diem Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
P11
P11: Cortical Lesion Detection using FLAWS in Multiple Sclerosis
Poster 2. Neuroinflammation / Neuroinfection
J. Müller Conférencier Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, F. La Rosa Signal Processing Laboratory (LTS5), École Polytechnique Fédérale de LausanneC. Tsagkas Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, R. Rahmanzadeh Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, J. Beaumont Univ Rennes, Inserm, LTSI-UMR1099M. Barakovic Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, P. Lu Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, Ö. Yaldizli Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, M. Weigel Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, L. Kappos Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, J. Kuhle Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering, M. Bach Cuadra Signal Processing Laboratory (LTS5), École Polytechnique Fédérale de LausanneG. Gambarota Univ Rennes, Inserm, LTSI-UMR1099C. Granziera Translational Imaging in Neurology (ThINk) Basel and Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience (NC2NB), Department of Biomedical Engineering,
P12
P12: Choroid Plexus Volume in Multiple Sclerosis versus Neuromyelitis Optica Spectrum Disorder
Poster 2. Neuroinflammation / Neuroinfection
J. Müller Conférencier Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitT. Sinnecker Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitM. Wendebourg Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitR. Schläger Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitJ. Kuhle Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitS. Schädelin Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitP. Benkert Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitT. Derfuss Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitP. Cattin Department of Biomedical Engineering, University of BaselC. Jud Department of Biomedical Engineering, University of BaselF. Spiess Department of Biomedical Engineering, University of BaselM. Amann Medical Imaging Analysis Center AGT. Lincke Section of Neuroradiology, Clinic for Radiology & Nuclear Medicine, University Hospital Basel and University of BaselM. Barakovic Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselA. Cagol Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselC. Tsagkas Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitA. Pröbstel Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitS. Reimann Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitS. Asseyer NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinA. Duchow NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinA. Brandt NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinK. Ruprecht Department of Neurology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu BerlinN. Hadjikhani Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical SchoolS. Fukumoto Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityM. Watanabe Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityK. Masaki Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityT. Matsushita Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityN. Isobe Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityJ. Kira Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu UniversityL. Kappos Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and UniversitJ. Würfel Medical Imaging Analysis Center AGC. Granziera Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, University Hospital Basel and University of BaselF. Paul NeuroCure Clinical Research Center and Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin BerlinÖ. Yaldizli Neurology Clinic and Policlinic, Departments of Head, Spine and Neuromedicine, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Clinical Research and Biomedical Engineering, University Hospital Basel and Universit
P13
P13: Case Report: Meningovascular neuroborreliosis with multiple strokes and persistent headache
Poster 2. Neuroinflammation / Neuroinfection
C. Achtnich Conférencier Kantonsspital St. GallenM. Fett Kantonsspital St. Gallen
P14
P14: Vaccination prior to Treatment with Ocrelizumab: A Retrospective Observational Study
Poster 2. Neuroinflammation / Neuroinfection
V. Epple Conférencier Universitätsspital BaselC. Berger Universitätsspital BaselS. Schaedelin Universitätsspital BaselP. Benkert Universitätsspital BaselL. Kappos Universitätsspital BaselK. Leuzinger Universitätsspital BaselH. Hirsch Universitätsspital BaselJ. Kuhle Universitätsspital BaselM. Mehling Universitätsspital Basel
P15
P15: Ganglion cell-inner plexiform layer is a marker of brain neuronal loss in multiple sclerosis
Poster 2. Neuroinflammation / Neuroinfection
A. Cagol Conférencier University of Basel / University Hospital BaselN. Cerda-Fuertes University of Basel / University Hospital BaselM. Stoessel University of Basel / University Hospital BaselM. Barakovic University of Basel / University Hospital BaselR. Rahmanzadeh University of Basel / University Hospital BaselR. Galbusera University of Basel / University Hospital BaselM. D' Souza University of Basel / University Hospital BaselJ. Wuerfel University Hospital Basel and University of Basel / Medical Image Analysis Center Basel AG, Basel, SwitzerlandT. Sprenger DKD Helios Klinik WiesbadenL. Kappos University of Basel / University Hospital BaselY. Naegelin University of Basel / University Hospital BaselJ. Kuhle University of Basel / University Hospital BaselC. Granziera University of Basel / University Hospital BaselA. Papadopoulou University of Basel / University Hospital Basel
P16
P16: Hypogammaglobulinemia: a possible cause of Multiple Sclerosis-related fatigue?
Poster 2. Neuroinflammation / Neuroinfection
L. Diem Conférencier Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieM. Evangelopoulos Eginition University Hospital, National and Kapodistrian University of AthensD. Karathanasis Eginition University Hospital, National and Kapodistrian University of AthensV. Natsis Eginition University Hospital, National and Kapodistrian University of AthensN. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieH. Hammer Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieC. Friedli Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
P17
P17: Ocrelizumab-related Neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS)
Poster 2. Neuroinflammation / Neuroinfection
H. Hammer Conférencier N. Kamber Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieM. Pistor Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieL. Diem Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieC. Friedli Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Chan Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieR. Hoepner Inselspital - Universitätsspital Bern - Universitätsklinik für NeurologieA. Salmen Inselspital - Universitätsspital Bern - Universitätsklinik für Neurologie
P18
P18: Lowering blood cholesterol does not affect inflammation in a murine model of multiple sclerosis
Poster 2. Neuroinflammation / Neuroinfection
S. Vigne Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)D. Duc Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)J. Rebeaud Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)B. Peter Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)F. Ruiz Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)Y. Yersin Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)V. Bressoud Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)T. Collet Geneva University Hospitals (HUG)C. Pot Conférencier Lausanne University Hospital (CHUV) and University of Lausanne (UNIL)
P19
P19: Prognostication of confirmed disease progression in patients with primary progressive MS (PPMS) by serum neurofilament light chain levels and multimodal evoked potentials
Poster 2. Neuroinflammation / Neuroinfection
M. Hardmeier Conférencier University Hospital Basel / University of BaselR. Schlaeger University Hospital Basel / University of BaselA. Lascano Geneva University Hospitals (HUG)L. Toffolet Neurocenter of southern Switzerland, Regional Hospital Lugano (EOC)C. Schindler University of Basel / Swiss TPHC. Gobbi Neurocenter of southern Switzerland, Regional Hospital Lugano (EOC)P. Lalive Geneva University Hospitals (HUG)D. Leppert University Hospital Basel / University of BaselL. Kappos University Hospital Basel / University of BaselP. Fuhr University Hospital Basel / University of BaselJ. Kuhle University Hospital Basel / University of Basel
P20
P20: Effects of Receptive Music Therapy with a Monochord in Multiple Sclerosis (MuTiMS) – a randomized controlled study
Poster 2. Neuroinflammation / Neuroinfection
J. Kuhlmann Universitätsspital BaselK. Ebner Universitätsspital BaselN. Cerdá Fuertes Universitätsspital BaselK. Parmar Rehabilitationsklinik RheinfeldenF. Helfenstein Universitätsspital BaselA. Zimmer Universitätsspital BaselA. Papadopoulou Conférencier Universitätsspital Basel
P21
P21: A case of SARS-CoV-2-associated acute disseminated encephalomyelitis
Poster 2. Neuroinflammation / Neuroinfection
N. Lohaus Conférencier Department of Neurology, University Hospital and University of ZurichI. Reichen Conférencier Department of Neurology, University Hospital and University of ZurichR. Reimann Institute of Neuropathology, University Hospital and University of ZurichI. Abela Department of Infectious Diseases and Hospital Epidemiology, University Hospital and University of ZurichI. Jelcic Conférencier Department of Neurology, University Hospital and University of Zurich
P22
P22: A case of posttransplant anti-GABA-A receptor antibody-associated autoimmune encephalitis
Poster 2. Neuroinflammation / Neuroinfection
C. Togni Conférencier Universitäts Spital ZürichM. Schubring-Giese Zuger KantonsspitalL. Imbach Klinik LenggI. Jelcic Universitäts Spital Zürich
P23
P23: MRZ reaction in MOG antibody-associated autoimmune disease and multiple sclerosis: a single-center experience
Poster 2. Neuroinflammation / Neuroinfection
I. Reichen Conférencier Department of Neurology, University Hospital and University of ZurichB. Vlad Conférencier Department of Neurology, University Hospital and University of ZurichD. Lekaditi Department of Neurology, University Hospital and University of ZurichC. Heuer Department of Neurology, University Hospital and University of ZurichA. Eisele Department of Neurology, University Hospital and University of ZurichM. Ziegler Department of Neurology, University Hospital and University of ZurichM. Reindl Clinical Department of Neurology, Medical University of InnsbruckA. Lutterotti Department of Neurology, University Hospital and University of ZurichA. Regeniter medica Medizinische Laboratorien Dr. F. Kaeppeli AGI. Jelcic Conférencier Department of Neurology, University Hospital and University of Zurich
P24
P24: HaNDL syndrome: 5 cases with negative CSF testing for metagenomic virus sequencing and autoimmune GFAP astrocytopathy
Poster 2. Neuroinflammation / Neuroinfection
I. Reichen Conférencier Department of Neurology, University Hospital and University of ZurichM. Huber Institute of Medical Virology, University of ZurichI. Jelcic Conférencier Department of Neurology, University Hospital and University of Zurich
P25
P25: Diagnostic and therapeutic challenges in Susac syndrome: Experiences from a case series
Poster 2. Neuroinflammation / Neuroinfection
T. Neziraj Conférencier Department of Neurology, University Hospital and University of ZurichI. Reichen Department of Neurology, University Hospital and University of ZurichM. Heider Department of Neurology, University Hospital and University of ZurichD. Gramatzki Department of Neurology, University Hospital and University of ZurichA. Pangalu Department of Neuroradiology, University Hospital and University of ZurichI. Jelcic Department of Neurology, University Hospital and University of ZurichM. Weller Department of Neurology, University Hospital and University of ZurichL. Steiner Department of Neurology, University Hospital and University of Zurich
P26
P26: Premotor and fronto-striatal mechanisms associated with presence hallucinations in dementia with Lewy bodies
Poster 3. Neurodegenerative diseases / Dementia
N. Nicastro Conférencier Hôpitaux Universitaires de GenèveG. Stripeikyte Ecole Polytechnique Federale de LausanneF. Assal Hôpitaux universitaire de GenèveV. Garibotto Hôpitaux universitaire de GenèveO. Blanke Ecole Polytechnique Federale de Lausanne
P27
P27: High efficacy therapies for multiple sclerosis in Switzerland – perception & expectations from Swiss neurologists
Poster 3. Neurodegenerative diseases / Dementia
G. Perriard Conférencier Novartis Pharma Schweiz AGM. Felder Novartis Pharma Schweiz AGN. Schäfer Novartis Pharma Schweiz AGM. Arzt Novartis Pharma Schweiz AG
P28
P28: Advanced neuroimaging, clinical and CSF biomarkers to predict symptom reversibility in idiopathic Normal Pressure Hydrocephalus
Poster 3. Neurodegenerative diseases / Dementia
A. Griffa Conférencier University of Geneva (UNIGE)G. Bommarito University of Geneva (UNIGE)F. Assal HUG Hôpitaux Universitaires GenèveF. Herrmann University of Geneva (UNIGE)D. Van De Ville Ecole Polytechnique Fédérale de Lausanne (EPFL)G. Allali HUG Hôpitaux Universitaires Genève
P29
P29: The Behavioural Dysfunction Questionnaire highly discriminates early-stage behavioural variant frontotemporal dementia from Alzheimer’s disease dementia and major depressive disorder
Poster 3. Neurodegenerative diseases / Dementia
A. Semenkova Conférencier Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Faculty of Psychology, University of BaselO. Piguet School of Psychology and Brain and Mind Centre, The University of SydneyA. Johnen Clinic for Neurology, Muenster University HospitalS. Bruchmann Clinic for Neurology, Muenster University HospitalM. Schroeter Clinic for Cognitive Neurology, University Hospital Leipzig / Max Planck Institute for Human Cognitive and Brain SciencesC. Linnemann University Psychiatric ClinicM. Mühlhauser University Psychiatric ClinicT. Sauer University Psychiatric ClinicM. Baumgartner memoryclinic-sonnweidS. Anderl-Straub Department of Neurology, University of UlmM. Otto Department of Neurology, University of Ulm / Department of Neurology, University Hospital HalleS. Zimmerer Clinic of Neurology and Neurophysiology, Canton Hospital St. GallenA. Felbecker Clinic of Neurology and Neurophysiology, Canton Hospital St. GallenR. Kressig University Department of Geriatric Medicine FELIX PLATTERM. Berres Faculty of Mathematics and Technology, University of Applied Sciences KoblenzM. Sollberger Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Department of Neurology, University Hospital Basel
P30
P30: The personalized assessment of regional cerebral perfusion and outlier symmetry in retired Canadian Football League players
Poster 3. Neurodegenerative diseases / Dementia
E. Danielli Conférencier McMaster UniversityB. Padrela Amsterdam University Medical Center, Amsterdam, The NetherlandsM. Doughty McMaster UniversityJ. Petr Helmholtz-Zentrum Dresden-RossendorfH. Mutsaerts Amsterdam University Medical Center, Amsterdam, The NetherlandsS. Ulmer neurorad.chM. Noseworthy McMaster University
P31
P31: Neurological Signal Complexity as a Diagnostic Tool of Alzheimer’s Disease
Poster 3. Neurodegenerative diseases / Dementia
E. Samson Conférencier N. Simard McMaster UniversityK. Zukotynski McMaster UniversityS. Krumm University of BaselS. Ulmer University hospital of Schleswig-HolsteinM. Noseworthy McMaster University
P32
P32: Cerebellar structural and functional damage present in retired Canadian Football League (CFL) players with a history of concussion
Poster 3. Neurodegenerative diseases / Dementia
N. Simard Conférencier TBIFinder inc.E. Danielli McMaster UniversityM. Doughty McMaster UniversityS. Ulmer neurorad.chM. Noseworthy St. Joseph's Healthcare Hamilton, McMaster University
P33
P33: COVID-19 infections and vaccinations in the Swiss Multiple Sclerosis Cohort Study
Poster 3. Neurodegenerative diseases / Dementia
V. Epple Neurologic Clinic, University Hospital BaselL. Hauss Neurologic Clinic, University Hospital BaselA. Orleth Neurologic Clinic, University Hospital BaselP. Benkert Clinical Trial Unit, Department of Clinical Research, University Hospital BaselD. Jorganxhi Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University BaselN. Sanderson Department of Biomedicine, University Hospital and University of BaselK. Ivánek Department of Biomedicine, University Hospital and University of BaselL. Kappos Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University BaselL. Achtnichts Department of Neurology, Cantonal Hospital AarauJ. Saxer Department of Neurology, Cantonal Hospital AarauC. Pot Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of LausanneP. Lim Dubois-Ferrière Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of LausanneP. Lalive Department of Neurology, University Hospital of Geneva (HUG)G. Breville Department of Neurology, University Hospital of Geneva (HUG)C. Bridel Department of Neurology, University Hospital of Geneva (HUG)C. Gobbi Department of Neurology, Neurocenter of Southern Switzerland, LuganoC. Zecca Department of Neurology, Neurocenter of Southern Switzerland, LuganoS. Mueller Department of Neurology, Cantonal Hospital St. GallenF. Gruenenfelder Department of Neurology, Cantonal Hospital St. GallenT. Derfuss Neurologic Clinic, University Hospital BaselC. Berger Department of Biomedicine, University Hospital and University of BaselR. Pedotti F. Hoffmann-La Roche Ltd.C. Raposo F. Hoffmann-La Roche Ltd.K. Leuzinger Department of Biomedicine, University Hospital and University of BaselH. Hirsch Department of Biomedicine, University Hospital and University of BaselJ. Kuhle Neurologic Clinic, University Hospital BaselM. Mehling Conférencier Neurologic Clinic, University Hospital Basel
P34
P34: The biological substrate of the Motoric Cognitive Risk syndrome: An Amyloid-/Tau-PET and MR imaging study
Poster 3. Neurodegenerative diseases / Dementia
G. Bommarito Conférencier Geneva University Hospitals and University of GenevaV. Garibotto Geneva University Hospitals and University of GenevaG. Frisoni Geneva University Hospitals and University of GenevaF. Ribaldi Geneva University Hospitals and University of GenevaS. Stampacchia Geneva University Hospitals and University of GenevaF. Assal Geneva University Hospitals and University of GenevaS. Armand Geneva University Hospitals and University of GenevaG. Allali Geneva University Hospitals and University of GenevaA. Griffa Geneva University Hospitals and University of Geneva
P35
P35: Post-Approval Safety of Cladribine Tablets With Particular Reference to COVID-19 Outcomes: An Update
Poster 3. Neurodegenerative diseases / Dementia
G. Giovannoni Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UKJ. Berger Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USAT. Leist Division of Clinical Neuroimmunology, Jefferson University, Comprehensive MS Center, Philadelphia, PA, USAD. Jack Merck KGaA, Darmstadt, GermanyA. Galazka Conférencier Merck KGaA, Darmstadt, GermanyA. Nolting Merck KGaA, Darmstadt, GermanyD. Damian EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany
P36
P36: Evobrutinib significantly reduces relapses and magnetic resonance imaging outcomes in patients with multiple sclerosis: association with baseline neurofilament light chain levels
Poster 3. Neurodegenerative diseases / Dementia
J. Kuhle Conférencier Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, and University of Basel, Basel, SwitzerlandL. Kappos Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, and University of Basel, SwitzerlandX. Montalban Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d'Hebron, Barcelona, SpainY. Li EMD Serono Research & Development Institute, Inc., Billerica, MA, USA (an affiliate of Merck KGaA, Darmstadt, Germany)K. Thangavelu EMD Serono Research & Development Institute, Inc., Billerica, MA, USA (an affiliate of Merck KGaA, Darmstadt, Germany)Y. Hyvert Merck KGaA, Darmstadt, GermanyD. Tomic Merck KGaA, Darmstadt, Germany
P37
P37: Exploratory Analysis of Serum GDF-15 Levels in Patients Receiving Subcutaneous Interferon Beta-1a in the REFLEX Trial
Poster 3. Neurodegenerative diseases / Dementia
M. Coray Conférencier University Hospital Basel and University of Basel, Department of Biomedicine, Basel, SwitzerlandA. Seitzinger Merck KGaA, Darmstadt, GermanyS. Roy Merck KGaA, Darmstadt, GermanyM. Freedman University of Ottawa, Department of Medicine and the Ottawa Hospital Research Institute, Ottawa, CanadaF. Barkhof VU University Medical Centre, Department of Radiology, Amsterdam, Netherlands; UCL Institute of Neurology, London, United KingdomG. Comi Università Vita-Salute San Raffaele, Ospedale San Raffaele, Department of Neurology and Institute of Experimental Neurology, Milan, ItalyN. De Stefano University of Siena, Department of Medicine, Surgery and Neuroscience, Siena, ItalyL. Kappos University Hospital Basel and University of Basel, Research Center Clinical Neuroimmunology and Neuroscience Basel, and MS Center, Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research and Biomedical Engineering, Basel,J. Kuhle University Hospital Basel and University of Basel, Research Center Clinical Neuroimmunology and Neuroscience Basel, and MS Center, Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research and Biomedical Engineering, Basel,M. Mehling University Hospital Basel and University of Basel, Research Center Clinical Neuroimmunology and Neuroscience Basel, and MS Center, Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine, Clinical Research and Biomedical Engineering, Basel,
P38
P38: Effect of diet on oral microbiota in Parkinson’s disease
Poster 3. Neurodegenerative diseases / Dementia
V. FLEURY Conférencier Hôpitaux Universitaire de Genève HUGA. Zekeridou University Clinic of Dental MedicineV. Lazarevic Geneva University HospitalsG. Piumatti Hôpitaux Universitaire de Genève HUGN. Gaïa University of Geneva (UNIGE)E. Berthouzoz University of Geneva (UNIGE)R. Goldstein Hôpitaux Universitaire de Genève HUGC. Giannopoulou University Clinic of Dental MedicineA. Mombelli University Clinic of Dental MedicineJ. Schrenzel Geneva University Hospitals (HUG)L. Genton Geneva University Hospitals (HUG)P. Burkhard Geneva University Hospitals (HUG)
P39
P39: Spatial organisation of protein aggregates on red blood cells as physical biomarkers of Alzheimer’s disease pathology
Poster 3. Neurodegenerative diseases / Dementia
P. Nirmalraj Empa, Swiss Federal Laboratories for Materials Science and Technology, Department Materials meet Life, St Gallen, SwitzerlandT. Schneider Conférencier Kantonsspital St. Gallen, Department of NeurologyA. Felbecker Kantonsspital St. Gallen, Department of Neurology
P40
P40: Different awareness domains contributes to explain emotional and behavioral disorders in mild Alzheimer’s disease
Poster 3. Neurodegenerative diseases / Dementia
l. sacco Conférencier Ente Ospedaliero CantonaleC. Defanti Center of Excellence for the treatment of Alzheimer's disease, European Biomedical Research FoundationN. Parietti Neurocenter of southern Switzerland, Department of Neurology, Memory Clinic, Neuropychology and Behavioral Neurology Research UnitS. Rossi Neurocenter of southern Switzerland, Department of Neurology, Memory Clinic, Neuropychology and Behavioral Neurology Research UnitP. Tiraboschi IRCCS Carlo BestaG. Riccitelli Neurocenter of southern Switzerland, Department of Neurology, Memory Clinic, Neuropychology and Behavioral Neurology Research Unit
P41
P41: Anxiety, depression, and apathy as predictors of cognitive decline in patients with Parkinson's disease- A three-year follow-up study
Poster 3. Neurodegenerative diseases / Dementia
K. Toloraia Conférencier University Hospital BaselA. Meyer University Hospital BaselS. Beltrani University Hospital BaselP. Fuhr University Hospital BaselR. Lieb University of BaselU. Gschwandtner University Hospital Basel
P42
P42: Deep brain stimulation as an adjunctive in drug resistant therapy: Analysis of success rate and possible predictors of response in a monocentric Swiss patient cohort.
Poster 4. Epilepsy / Sleep
A. Belvedere UnsiversitätsSpital Zürich, Klinik für NeurologieR. Renzel Conférencier Swiss Epilepsy Clinic, Klinik Lengg AGL. Stieglitz Klinik für Neurochirurgie, Universitätsspital ZürichL. Imbach Swiss Epilepsy Clinic, Klinik Lengg AG
P43
P43: Management of Lambert-Eaton Myasthenic Syndrome (LEMS) in the context of immunecheckpoint-inhibitor treatment – A Clinical Case Report
Poster 5. Neuromuscular disorders
B. Wagner Conférencier Kantonsspital St. GallenA. Beuttler Kantonsspital St. GallenN. Kiriakidis Kantonsspital St. GallenM. Jörger Kantonsspital St. GallenR. Käufeler Neurologische Praxis St. GallenT. Hundsberger Kantonsspital St. Gallen
P44
P44: Patients with amyotrophic lateral sclerosis without behavioural disorders are not impaired in recognising negative facial emotions
Poster 5. Neuromuscular disorders
C. Gerber Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Faculty of Psychology, University of Basel D. Lulé Department of Neurology, Ulm University Medical CenterN. Braun Kantonsspital St. Gallen Muskelzentrum / ALS ClinicK. Schweikert ALS Sprechstunde, REHAB Basel / Department of Neurology, University Hospital Basel M. Weber Kantonsspital St. Gallen Muskelzentrum / ALS ClinicR. Kressig University Department of Geriatric Medicine FELIX PLATTERO. Piguet School of Psychology and Brain and Mind Centre, The University of SydneyM. Sollberger Conférencier Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Department of Neurology, University Hospital Basel
P45
P45: Neuromuscular ultrasound (NMU) as a decisive diagnostic tool diagnosing myasthenia gravis as an underlying cause of respiratory failure: a case report
Poster 5. Neuromuscular disorders
N. Kiriakidis Conférencier Kantonsspital St. GallenD. Leupold Kantonsspital St. GallenG. Kägi Kantonsspital St. GallenG. Kleger Kantonsspital St. GallenB. Tettenborn Kantonsspital St. Gallen
P46
P46: Volar wrist arthrodesis for treatment of the spastic wrist
Poster 5. Neuromuscular disorders
E. Rothenfluh Conférencier UniversitaetsSpital ZuerichA. Schiller UniversitaetsSpital ZuerichC. Erling Manus PraxisI. Besmens UniversitaetsSpital ZuerichM. Calcagni UniversitaetsSpital Zuerich
P47
P47: Adult-onset distal Spinal Muscular Atrophy (SMA) with identification of heterozygous VRK1-gene mutation – case closed?
Poster 5. Neuromuscular disorders
A. Oertli Luzerner Kantonsspital (LUKS)E. Wilder-Smith Conférencier Luzerner Kantonsspital (LUKS)
P48
P48: Botulinum toxin restores sleep homeostasis in cervical dystonia
Poster 6. Movement disorders
S. Caverzasio Conférencier Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoN. Amato Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoG. Chiaro Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoC. Staedler Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoA. Kaelin-Lang Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), LuganoS. Galati Neurocenter of Southern Switzerland, Regional Hospital Lugano (EOC), Lugano
P49
P49: Does quantitative electroencephalography refine preoperative cognitive assessment in Parkinson’s disease patients treated with Deep Brain Stimulation? A follow-up study
Poster 6. Movement disorders
C. Saleh Conférencier University Hospital BaselA. Meyer University Hospital BaselM. Chaturvedi University Hospital BaselS. Beltrani University Hospital BaselU. Gschwandtner University Hospital BaselP. Fuhr University Hospital Basel
P50
P50: Perfect 50: Reduced Alpha suppression & altered EEG signal complexity in Parkinson’s disease – signatures of cognitive impairment?
Poster 6. Movement disorders
S. Keller Conférencier University Hospital BaselA. Meyer University Hospital BaselU. Gschwandtner University Hospital BaselS. Beltrani University Hospital BaselK. Toloraia University Hospital BaselP. Fuhr University Hospital Basel
P51
P51: The Basel Version of the Awareness of Social Inference Test – Theory of Mind (BASIT-ToM): Preliminary Validation Analyses in Healthy Subjects
Poster 7. Others
M. Jarsch Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Faculty of Psychology, University of Basel O. Piguet School of Psychology and Brain and Mind Centre, The University of SydneyC. Sluka University of Basel and University Hospital BaselN. Huber Memory Clinic, University Department of Geriatric Medicine FELIX PLATTERR. Kressig University Department of Geriatric Medicine FELIX PLATTERA. Monsch Memory Clinic, University Department of Geriatric Medicine FELIX PLATTERM. Berres Faculty of Mathematics and Technology, University of Applied Science KoblenzM. Sollberger Conférencier Memory Clinic, University Department of Geriatric Medicine FELIX PLATTER / Department of Neurology, University Hospital Basel
P52
P52: iPhone Exophthalmometry: A Novel Approach to Measure Eyeball Protrusion
Poster 7. Others
T. Popov Conférencier Universitätsspital ZürichF. Fierz Universitätsspital ZürichC. Bockisch Universitätsspital Zürich, Neurology/Ophthalmology/ENTK. Weber Universitätsspital Zürich, Neurology & Ophthalmology
P53
P53: Beyond conventional MRI: improving sensitivity in mTBI imaging of individual patients - a case-control-study
Poster 7. Others
S. Ulmer Conférencier neurorad.chA. Palla Swiss Concussion CenterC. Fuchs SportClinic ZürichN. Simard TBI FinderM. Noseworthy McMaster University
P54
P54: Real-world effectiveness data of erenumab-treated migraine patients in Switzerland: The SQUARE study
Poster 7. Others
E. Schäfer Novartis Pharma Schweiz AGM. Arzt Conférencier Novartis Pharma Schweiz AGI. Meyer Novartis Pharma Schweiz AGA. Gantenbein Conférencier RehaClinic Bad Zurzach
P55
P55: Effect of transcranial direct current stimulation in a patient with frontal chronic post-traumatic encephalopathy
Poster 7. Others
A. Dontschev Conférencier UNI FRIBOURGL. Rochat HFR - hôpital fribourgeoisM. Mouthon UNI FRIBOURGJ. Annoni UNI FRIBOURGF. Ribordy Lambert UNI FRIBOURG
P56
P56: Anosognosia for memory dysfunction as a key determinant of cognitive and psychiatric symptoms in long COVID
Poster 7. Others
P. Voruz Conférencier Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland G. Allali Hôpitaux Universitaire de Genève HUGL. Benzakour Hôpitaux Universitaire de Genève HUGA. Nuber-Champier Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland M. Thomasson Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland I. Jacot de Alcantara Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland A. Cionca Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland P. Lalive d'Epinay Hôpitaux Universitaire de Genève HUGK. Lövblad Hôpitaux Universitaire de Genève HUGM. Nehme Hôpitaux Universitaire de Genève HUGO. Braillard Hôpitaux Universitaire de Genève HUGM. Coen Hôpitaux Universitaire de Genève HUGJ. Serratrice Hôpitaux Universitaire de Genève HUGJ. Reny Hôpitaux Universitaire de Genève HUGJ. Pugin Hôpitaux Universitaire de Genève HUGI. Guessous Hôpitaux Universitaire de Genève HUGB. Landis Hôpitaux Universitaire de Genève HUGF. Assal Hôpitaux Universitaire de Genève HUGJ. Péron Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland
P57
P57: Ocular lateral deviation – a clinical sign pointing to lateral medullary lesions
Poster 7. Others
M. Spiegelberg Kantonsspital Baden AGA. Tarnutzer Conférencier Kantonsspital Baden AG
P58
P58: Brain structures of early diglossic bilinguals: Impact of German / Swiss German bilingualism on grey matter density of language control areas in university students
Poster 7. Others
L. Berger Conférencier BMed, Faculty of Science and Medicine of the University of Fribourg, SwitzerlandM. Mouthon PhD, Faculty of Science and Medicine-Neurology Unit of the University of Fribourg, SwitzerlandL. Jost PhD, Laboratory for Cognitive and Neurological Science (LCNS) of the University of Fribourg, SwitzerlandJ. Annoni Prof. Dr. med., Faculty of Science University of Fribourg- Neurology unit, Fribourg Hospital, Switzerland
P59
P59: Case report: Response of corticotroph adenoma to Temozolomide in a patient with Nelson syndrome
Poster 7. Others
M. Baldauf Conférencier KSSG Kantonsspital St. GallenW. Jochum KSSG Kantonsspital St. GallenA. Lauber KSSG Kantonsspital St. GallenT. Hundsberger KSSG Kantonsspital St. GallenM. Brändle KSSG Kantonsspital St. Gallen
P60
P60: Long-term regional quantification of microstructural and functional abnormalities in retired Canadian Football League players
Poster 7. Others
E. Danielli McMaster UniversityN. Simard TBIFinder inc.M. Doughty McMaster UniversityS. Ulmer neurorad.chD. Kumbhare University of TorontoM. Noseworthy Conférencier McMaster University
P61
P61: Migraine diagnosis made in time could prevent emergency room visits - a prospective observational study
Poster 7. Others
H. Drangova Conférencier Inselspital - Universitätsspital Bern